Dendritic with cytokine-induced killer cells (Shenzhen Hornetcorn)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameDendritic with cytokine-induced killer cells (Shenzhen Hornetcorn)
Drug Alias NameDCIK - Shenzhen Hornetcorn BiotechnologyDC-CIK - Shenzhen Hornetcorn BiotechnologyAg-D-CIK - Shenzhen Hornetcorn BiotechnologyAutologous dendritic cell cytokine-induced killer cell therapy - Shenzhen HornetcornDC-CIK Biotherapy - Shenzhen Hornetcorn Biotechnology +[8] 
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cell
Mechanisms of ActionImmunostimulantsCytokine-induced killer cells stimulantsCytokine-induced killer cells inhibitors
TargetsNot applicable
Therapy Area/IndicationsGastrointestinal DiseasesCarcinoma, Non-Small-Cell LungLung Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesShenzhen Hornetcorn Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenzhen Hornetcorn Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsGastrointestinal DiseasesCarcinoma, Non-Small-Cell LungLung Neoplasms +[10] 

Other Information

ATC CodeN/A
Related LinksN/A